Literature DB >> 18992021

Methamphetamine abuse and dentistry.

D T Hamamoto1, N L Rhodus.   

Abstract

Methamphetamine is a highly addictive powerful stimulant that increases wakefulness and physical activity and produces other effects including cardiac dysrhythmias, hypertension, hallucinations, and violent behavior. The prevalence of methamphetamine use is estimated at 35 million people worldwide and 10.4 million people in the United States. In the United States, the prevalence of methamphetamine use is beginning to decline but methamphetamine trafficking and use are still significant problems. Dental patients who abuse methamphetamine can present with poor oral hygiene, xerostomia, rampant caries ('Meth mouth'), and excessive tooth wear. Dental management of methamphetamine users requires obtaining a thorough medical history and performing a careful oral examination. The most important factor in treating the oral effects of methamphetamine is for the patient to stop using the drug. Continued abuse will make it difficult to increase salivary flow and hinder the patient's ability to improve nutrition and oral hygiene. Local anesthetics with vasoconstrictors should be used with care in patients taking methamphetamine because they may result in cardiac dysrhythmias, myocardial infarction, and cerebrovascular accidents. Thus, dental management of patients who use methamphetamine can be challenging. Dentists need to be aware of the clinical presentation and medical risks presented by these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992021     DOI: 10.1111/j.1601-0825.2008.01459.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  39 in total

1.  Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-12       Impact factor: 4.147

2.  The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice.

Authors:  Sarah E Snider; Sarah A Vunck; Edwin J C G van den Oord; Daniel E Adkins; Joseph L McClay; Patrick M Beardsley
Journal:  Eur J Pharmacol       Date:  2012-01-28       Impact factor: 4.432

Review 3.  The implications of substance misuse for intravenous conscious sedation practice.

Authors:  J Noone; E Critchley; P Cullingham; P Coulthard; A Saksena
Journal:  Br Dent J       Date:  2015-02       Impact factor: 1.626

4.  Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Stanley A Schwartz
Journal:  Immunol Invest       Date:  2011-03-22       Impact factor: 3.657

5.  Effect of methamphetamine dependence on heart rate variability.

Authors:  Brook L Henry; Arpi Minassian; William Perry
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

6.  The impact of the new scene drug "crystal meth" on oral health: a case-control study.

Authors:  Niklas Rommel; Nils H Rohleder; Stefan Wagenpfeil; Roland Härtel-Petri; Frederic Jacob; Klaus-Dietrich Wolff; Marco R Kesting
Journal:  Clin Oral Investig       Date:  2015-07-15       Impact factor: 3.573

Review 7.  Khat use and appetite: an overview and comparison of amphetamine, khat and cathinone.

Authors:  Andrine M Lemieux; Bingshuo Li; Mustafa al'Absi
Journal:  J Ethnopharmacol       Date:  2014-11-28       Impact factor: 4.360

8.  Screening for substance misuse in the dental care setting: findings from a nationally representative survey of dentists.

Authors:  Carrigan L Parish; Margaret R Pereyra; Harold A Pollack; Gabriel Cardenas; Pedro C Castellon; Stephen N Abel; Richard Singer; Lisa R Metsch
Journal:  Addiction       Date:  2015-07-02       Impact factor: 6.526

9.  Sublingual buprenorphine and dental problems: a case series.

Authors:  Joji Suzuki; Leena Mittal; Sook-Bin Woo
Journal:  Prim Care Companion CNS Disord       Date:  2013

10.  "Tweaking and geeking, just having some fun": an analysis of methamphetamine poems.

Authors:  Rocky L Sexton; Robert G Carlson; Carl G Leukefeld; Brenda M Booth
Journal:  J Psychoactive Drugs       Date:  2010-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.